ICH goes Risk-based!

Beat Widler co-authors article in Applied Clinical Trials (ACT)

Artem Andrianov, Managing Director at Cyntegrity, Beat Widler, Managing Partner at Widler & Schiemann and María Proupín-Pérez, Project Leader at PPH plus interpret the new ICH E6 addendum’s implication on Clinical Development. Risk Management, Quality Management, Risk-based Monitoring and CRO oversight are the main topics. Read more at:

Read more online
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /